Skip to main content

Colcrys FDA Approval History

FDA Approved: Yes (First approved July 29, 2009)
Brand name: Colcrys
Generic name: colchicine
Dosage form: Tablets
Company: Mutual Pharmaceutical Company, Inc.
Treatment for: Gout, Familial Mediterranean Fever, Gout, Prophylaxis, Gout, Acute

Colcrys (colchicine) is compound derived from the dried seeds of the autumn crocus or meadow saffron (Colchicum autumnale). Colcrys is approved for the prophylaxis and treatment of acute gout flares, and for the treatment of patients with familial Mediterranean fever.

Development timeline for Colcrys

Oct 22, 2009Approval FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares
Jul 31, 2009Approval FDA Approves Colcrys (colchicine) for Acute Gout, Mediterranean Fever

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.